你即將離開本站

並前往https://protalixbiotherapeutics.gcs-web.com/news-releases/news-release-details/protalix-biotherapeutics-and-chiesi-global-rare-diseases-4

Press Releases - Protalix BioTherapeutics

Protalix Biotherapeutics and Chiesi Global Rare Diseases Provide Regulatory Update on PRX-102 for the Treatment of Fabry Disease.

確定！ 回上一頁

查詢 「PRX Impact Factor」的人也找了：

  1. PRL impact Factor
    2.
  2. PRX Quantum impact factor
    3.
  3. Physical Review Research impact factor
    4.
  4. Physical Review X
    5.
  5. Physical Review B
    6.
  6. Physical Review A impact Factor 2020
    7.
  7. Physical Review Letters
    8.
  8. Science impact factor
    9.